Abstract:
The present invention provides a compound of formula I: or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3, Aurora2, and Syk mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatement of various protein kinase mediated disorders.
Abstract:
The present invention provides compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein A, B, Ra, R1, R2, R3 and R4 are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of JNK, a mammalian protein kinase involved in cell proliferation, cell death and response to extracellular stimuli; Lck and Src kinase. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
Abstract:
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Abstract:
Un compuesto de formula (IB): **Fórmula** o sales farmaceuticamente aceptables del mismo, en la que: R1 es T-R' o es -Si(R')3; cada uno de R2, R3 y R4 es independientemente halogeno, -CN, -NO2 o V-R'; x es 1, 2 o 3; en cada aparicion, R5 es independientemente halogeno, -CN, -NO2 o U-R', en el que al menos un R5 es distinto de H; cada uno de T, V y U es independientemente un enlace o una cadena de alquilideno-C1-C6 opcionalmente sustituida, en la que hasta dos unidades de metileno de la cadena estan opcionalmente e independientemente sustituidas con -NR'-, -S-, -O- -CS-, -CO2-, -OCO-, -CO-, -COCO-, -CONR'-, -NR'CO-, - NR'CO2-, -SO2NR'-, - NR'SO2-, -CONR'NR'-, -NR'CONR'-, -OCONR'-, -NR'NR'-, - NR'SO2NR'-, -SO-, -SO2-, -PO-, -PO2- o -POR'-; y en cada aparicion, R es independientemente hidrogeno o un grupo opcionalmente sustituido seleccionado entre un grupo alifatico-C1-C6, un anillo monociclico saturado, parcialmente insaturado o totalmente insaturado de 3-8 miembros que tiene 0-3 heteroatomos seleccionados independientemente entre nitrogeno, oxigeno o azufre, o un sistema de anillos biciclico saturado, parcialmente insaturado o totalmente insaturado de 8-12 miembros que tiene 0-5 heteroatomos seleccionados independientemente entre nitrogeno, oxigeno o azufre; o dos apariciones de R se toman junto con el atomo o atomos a los que estan unidas para formar un anillo monociclico o biciclico, opcionalmente sustituido, saturado, parcialmente insaturado o totalmente insaturado de 3-12 miembros que tiene 0-4 heteroatomos seleccionados independientemente entre nitrogeno, oxigeno o azufre, con la condicion de que: a) si R2, R3 y R4 son simultaneamente H, entonces R1 no sea Si(R')3; y b) si R1, R2 y R4 son simultaneamente H entonces R3 no sea fenilo o fenilo sustituido con O-fenilo o N(Me)2.
Abstract:
The present invention provides a compound of formula I: or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3, Aurora2, and Syk mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
Abstract:
La presente invencion se relaciona con compuestos de la formula (I), (ver formula (I)) que son inhibidores de proteinas cinasas. La invencion tambien proporciona composiciones farmaceuticas que comprenden los compuestos de la invencion y los metodos para utilizar las composiciones en el tratamiento de diversos trastornos.
Abstract:
The present invention relates to compounds of formula (I), which are inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.